547 related articles for article (PubMed ID: 16405540)
1. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
2. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
3. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup.
Binion DG; Kugathasan S; Dwinell MB
Am J Gastroenterol; 2006 Jan; 101(1):107-9. PubMed ID: 16405541
[TBL] [Abstract][Full Text] [Related]
4. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.
Amanatidou V; Sourvinos G; Apostolakis S; Tsilimigaki A; Spandidos DA
Pediatr Infect Dis J; 2006 May; 25(5):410-4. PubMed ID: 16645504
[TBL] [Abstract][Full Text] [Related]
5. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
[TBL] [Abstract][Full Text] [Related]
6. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
7. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
Mühlbauer M; Ringel S; Hartmann A; Lallinger G; Weiss TS; Gäbele E; Wünsch PH; Schölmerich J; Hellerbrand C
Oncol Rep; 2005 May; 13(5):957-63. PubMed ID: 15809764
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
Blaschke S; Koziolek M; Schwarz A; Benöhr P; Middel P; Schwarz G; Hummel KM; Müller GA
J Rheumatol; 2003 Sep; 30(9):1918-27. PubMed ID: 12966591
[TBL] [Abstract][Full Text] [Related]
11. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
Wasmuth HE; Zaldivar MM; Berres ML; Werth A; Scholten D; Hillebrandt S; Tacke F; Schmitz P; Dahl E; Wiederholt T; Hellerbrand C; Berg T; Weiskirchen R; Trautwein C; Lammert F
J Hepatol; 2008 Feb; 48(2):208-15. PubMed ID: 18078680
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
[TBL] [Abstract][Full Text] [Related]
13. Association study between the CX3CR1 gene and asthma.
Tremblay K; Lemire M; Provost V; Pastinen T; Renaud Y; Sandford AJ; Laviolette M; Hudson TJ; Laprise C
Genes Immun; 2006 Dec; 7(8):632-9. PubMed ID: 17082760
[TBL] [Abstract][Full Text] [Related]
14. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
Nassar BA; Nanji AA; Ransom TP; Rockwood K; Kirkland SA; Macpherson K; Connelly PW; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Title LM
Scand J Clin Lab Invest; 2008; 68(4):286-91. PubMed ID: 18609106
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension.
Marasini B; Cossutta R; Selmi C; Pozzi MR; Gardinali M; Massarotti M; Erario M; Battaglioli L; Biondi ML
Clin Dev Immunol; 2005 Dec; 12(4):275-9. PubMed ID: 16584113
[TBL] [Abstract][Full Text] [Related]
17. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Matsubara T; Ono T; Yamanoi A; Tachibana M; Nagasue N
J Surg Oncol; 2007 Mar; 95(3):241-9. PubMed ID: 17323338
[TBL] [Abstract][Full Text] [Related]
19. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
Sirois-Gagnon D; Chamberland A; Perron S; Brisson D; Gaudet D; Laprise C
Obesity (Silver Spring); 2011 Jan; 19(1):222-7. PubMed ID: 20523302
[TBL] [Abstract][Full Text] [Related]
20. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.
Hosokawa Y; Nakanishi T; Yamaguchi D; Nakae H; Matsuo T
Clin Exp Immunol; 2005 Mar; 139(3):506-12. PubMed ID: 15730397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
